西澳大利亚州儿童乙型肝炎疫苗接种规划对原住民与非原住民产妇乙型肝炎病毒携带率的长期影响
该研究利用出生登记与选民名册建立1974至1995年出生的西澳大利亚州女性队列,链接围产期登记与法定传染病登记,评估2000至2012年首次分娩女性的乙型肝炎病毒(HBV)感染情况。结果显示原住民产妇HBV携带率是非原住民的五倍,且原住民中出生于疫苗接种时代者风险显著降低。
要点
- 原住民产妇HBV携带率0.92%(95%CI 0.65-1.18),非原住民为0.18%(0.15-0.21),前者约为后者的五倍。
- 原住民中出生于1988-1995年疫苗接种时代者,HBV风险较1974-1981年出生者降低89%(aOR 0.11,95%CI 0.04-0.33)。
- 非原住民中不同出生年代HBV携带率无显著差异(p=0.20),但非白人女性风险约为白人的36倍(aOR 36.08,95%CI 22.66-57.46)。
核心结论
- 西澳大利亚州引入HBV疫苗接种规划后,原住民分娩母亲HBV携带率显著下降,但不同居住地区和族裔之间仍存在较大差异。
- 作者指出该发现与其他澳大利亚辖区女性中观察到的结果一致。
- 作者认为持续监测分娩母亲HBV携带率可提供疫苗接种规划影响及慢性HBV高危人群的持续估计。
研究设计与样本
- 利用出生登记与选民名册记录建立1974至1995年出生的西澳大利亚州女性队列。
- 将队列链接至围产期登记和法定传染病登记,识别2000至2012年间首次分娩及HBV感染诊断。
- 共纳入66,073名女性,其中155名(0.23%)有链接的非急性HBV通报。
主要发现
- 原住民女性HBV携带率为0.92%(95%CI 0.65-1.18),非原住民女性为0.18%(95%CI 0.15-0.21),原住民约为非原住民的五倍。
- 原住民中,调整分娩年份和居住地区后,出生于1988-1995年婴幼儿及学校接种时代者较1974-1981年未接种时代者HBV风险降低89%(aOR 0.11,95%CI 0.04-0.33)。
- 原住民中居住在农村/偏远地区者HBV风险高于主要城市居民(aOR 3.06,95%CI 1.36-6.88)。
- 非原住民中HBV携带率按出生年代无显著差异(p=0.20),按居住地也无显著差异(p=0.23),但非白人女性较白人女性风险高36倍(aOR 36.08,95%CI 22.66-57.46)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To evaluate the long-term effect of infant and childhood hepatitis B (HBV) vaccination programs among birthing women in Western Australia. METHODS: A cohort of Western Australian women born from 1974 to 1995 was created using Birth Registrations and Electoral Roll records. They were linked to a perinatal register and notifiable diseases register to identify women having respectively their first births between 2000 and 2012 and diagnoses of HBV infections. HBV prevalence was estimated in Aboriginal and non-Aboriginal women, and according to maternal birth year cohorts. RESULTS: Of 66,073 women, 155 (0.23%) had a linked non-acute HBV notification. HBV prevalence was five times higher in Aboriginal women compared to their non-Aboriginal counterparts (0.92%, 95%CI 0.65-1.18 versus 0.18%, 0.15-0.21). Among Aboriginal women, after adjusting for year of giving birth and region of residence, those born in the targeted infant and school-based vaccination era (maternal year of birth 1988-1995) had an 89% lower risk (adjusted odds ratio [aOR] 0.11, 0.04-0.33) of HBV than those born in the pre-vaccination era (1974-1981). Prevalence also differed between Aboriginal women residing in rural/remote areas compared to those in major cities (aOR 3.06, 1.36-6.88). Among non-Aboriginal women, no significant difference in HBV prevalence was observed by maternal birth cohort (p = 0.20) nor by residence (p = 0.23), but there were significant differences by ethnicity with a 36-fold higher prevalence (aOR 36.08, 22.66-57.46) in non-Caucasian versus Caucasian women. CONCLUSIONS: A significant decline in HBV prevalence in Aboriginal birthing mothers was observed following the introduction of HBV vaccination programs in Western Australia. There were also considerable disparities in prevalence between women by area of residence and ethnicity. Our findings reflect those observed in women in other Australian jurisdictions. Continued surveillance of HBV prevalence in birthing mothers will provide ongoing estimates of HBV vaccination program impact across Australia and the populations most at risk of chronic HBV.
引用
- Reekie J, Kaldor JM, Mak DB, et al. Long-term impact of childhood hepatitis B vaccination programs on prevalence among Aboriginal and non-Aboriginal women giving birth in Western Australia. Vaccine. 2018. PMID: 29706293. doi:10.1016/j.vaccine.2018.04.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。